Absence of E17K mutation in the pleckstrin homology domain of AKT1 in gastrointestinal and liver cancers in the Korean population

被引：2
|
作者：
Cao, Zhang [1 ]
Song, Jae Hwi [1 ]
Kim, Chang Jae [1 ]
Cho, Yong Gu [1 ]
Kim, Su Young [1 ]
Nam, Suk Woo [1 ]
Lee, Jung Young [1 ]
Park, Won Sang [1 ]
机构：
[1] Catholic Univ, Dept Pathol, Coll Med, Seoul 137701, South Korea
来源：
APMIS | 2008年 / 116卷 / 06期
关键词：
D O I：
10.1111/j.1600-0463.2008.00998.x
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：530 / 533
页数：4
相关论文
共 50 条
  • [41] AKT1 (E17K) mutation: coexistence with oncogenic alterations, prevalence, and correlation to clinical parameter in a large series of breast cancer patients
    Rudolph, Marion
    Anzeneder, Tobias
    Ocker, Matthias
    Lagkadinou, Eleni
    Politz, Oliver
    Michels, Martin
    Schulz, Anke
    Beckmann, Georg
    Teufel, Michael
    Seidel, Henrik
    Soong, Richie
    Bodenmueller, Heinz
    Ohlms, Ulla
    Asadullah, Khusru
    Reischl, Joachim
    CANCER RESEARCH, 2014, 74 (19)
  • [42] Analysis of oncogenic AKT1 p.E17K mutation in carcinomas of the biliary tract and liver
    Riener, M-O
    Bawohl, M.
    Clavien, P-A
    Jochum, W.
    BRITISH JOURNAL OF CANCER, 2008, 99 (05) : 836 - 836
  • [43] Analysis of oncogenic AKT1 p.E17K mutation in carcinomas of the biliary tract and liver
    M-O Riener
    M Bawohl
    P-A Clavien
    W Jochum
    British Journal of Cancer, 2008, 99 : 836 - 836
  • [44] Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations
    J Lauring
    D P Cosgrove
    S Fontana
    J P Gustin
    H Konishi
    A M Abukhdeir
    J P Garay
    M Mohseni
    G M Wang
    M J Higgins
    D Gorkin
    M Reis
    B Vogelstein
    K Polyak
    M Cowherd
    P J Buckhaults
    B H Park
    Oncogene, 2010, 29 : 2337 - 2345
  • [45] Use of iterative in situ click chemistry to develop a capture agent specific for a transforming point mutation in the pleckstrin homology domain of Akt1
    Deyle, Kaycie M.
    Hee, Ying Qiao
    Millward, Steven
    Heath, James
    CANCER RESEARCH, 2013, 73 (08)
  • [46] Ubiquitous expression of Akt1 p.(E17K) results in vascular defects and embryonic lethality in mice
    Lindhurst, Marjorie J.
    Li, Wenling
    Laughner, Nathaniel
    Shwetar, Jasmine J.
    Kondolf, Hannah C.
    Ma, Xuefei
    Mukouyama, Yoh-Suke
    Biesecker, Leslie G.
    HUMAN MOLECULAR GENETICS, 2020, 29 (20) : 3350 - 3360
  • [47] Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations
    Lauring, J.
    Cosgrove, D. P.
    Fontana, S.
    Gustin, J. P.
    Konishi, H.
    Abukhdeir, A. M.
    Garay, J. P.
    Mohseni, M.
    Wang, G. M.
    Higgins, M. J.
    Gorkin, D.
    Reis, M.
    Vogelstein, B.
    Polyak, K.
    Cowherd, M.
    Buckhaults, P. J.
    Park, B. H.
    ONCOGENE, 2010, 29 (16) : 2337 - 2345
  • [48] Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer
    Bose, Sminu
    Kalinsky, Kevin
    CLINICAL BREAST CANCER, 2021, 21 (03) : E150 - E153
  • [49] A functional and proteomics analysis of AKT1(E17K) in human mammary epithelial cells of luminal and myoepithelial cells of origin
    Salhia, Bodour
    DuQuette, Rachelle A.
    Van Cott, Courtney
    Tegler, Tony
    Polpitiya, Ashoka
    Petritis, Konstantinos
    Carpten, John
    CANCER RESEARCH, 2011, 71
  • [50] Sumoylation and the oncogenic E17K mutation affect AKT1 subcellular distribution and impact on Nanog-binding dynamics to chromatin in embryonic stem cells
    Francia, Marcos Gabriel
    Oses, Camila
    Garcia, Mora Renee
    Roberti, Sabrina Lorena
    Garcia, Mora Renee
    Cozza, Lucas Helio
    Diaz, Maria Candelaria
    Levi, Valeria
    Guberman, Alejandra Sonia
    JOURNAL OF STRUCTURAL BIOLOGY, 2023, 215 (02)
12345